This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 May 4;84(9):1143-5.

doi: 10.1054/bjoc.2000.1740.

Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?

PMID: 11336462
PMCID: PMC2363895
DOI: 10.1054/bjoc.2000.1740

Free PMC article

Editorial

Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?

A Bahl et al. Br J Cancer. 2001.

Free PMC article

. 2001 May 4;84(9):1143-5.

doi: 10.1054/bjoc.2000.1740.

Authors

PMID: 11336462
PMCID: PMC2363895
DOI: 10.1054/bjoc.2000.1740

No abstract available

PubMed Disclaimer

Comment on

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature.
Sculier JP, Ghisdal L, Berghmans T, Branle F, Lafitte JJ, Vallot F, Meert AP, Lemaitre F, Steels E, Burniat A, Mascaux C; European Lung Cancer Working Party. Sculier JP, et al. Br J Cancer. 2001 May 4;84(9):1150-5. doi: 10.1054/bjoc.2001.1742. Br J Cancer. 2001. PMID: 11336463 Free PMC article.

Similar articles

Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E, Gralla RJ, Raftopoulos H, Cuppone F, Milella M, Sperduti I, Carlini P, Terzoli E, Cognetti F, Giannarelli D. Bria E, et al. Lung Cancer. 2009 Jan;63(1):50-7. doi: 10.1016/j.lungcan.2008.05.002. Epub 2008 Jun 18. Lung Cancer. 2009. PMID: 18565615
Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better.
Sasse AD, Lima JP, Sasse EC, Santos LV. Sasse AD, et al. J Clin Oncol. 2009 Dec 10;27(35):e253; author reply e254. doi: 10.1200/JCO.2009.25.1918. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884522 No abstract available.
[Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
Le Chevalier T. Le Chevalier T. Rev Pneumol Clin. 2002 Nov;58(5 Pt 2):3S31-2. Rev Pneumol Clin. 2002. PMID: 12538932 French. No abstract available.
Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE, Rabin MS. Johnson BE, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5022s-5026s. doi: 10.1158/1078-0432.CCR-05-9001. Clin Cancer Res. 2005. PMID: 16000607 Review.
Adjuvant chemotherapy for non-small cell lung cancer.
Solomon B, Bunn PA Jr. Solomon B, et al. Cancer Invest. 2007 Jun;25(4):217-25. doi: 10.1080/07357900701206281. Cancer Invest. 2007. PMID: 17612931 Review.

See all similar articles

Cited by

A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J, Yin Z, Shen H, Gao W, Qian Y, Pei D, Liu L, Shu Y. Xu J, et al. PLoS One. 2013 Nov 6;8(11):e79135. doi: 10.1371/journal.pone.0079135. eCollection 2013. PLoS One. 2013. PMID: 24223174 Free PMC article.
Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
Singh A, Singh N, Behera D, Sharma S. Singh A, et al. Med Oncol. 2017 Apr;34(4):64. doi: 10.1007/s12032-017-0923-4. Epub 2017 Mar 22. Med Oncol. 2017. PMID: 28332164
Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
Zhang R, Jia M, Xue H, Xu Y, Wang M, Zhu M, Sun M, Chang J, Wei Q. Zhang R, et al. Sci Rep. 2017 Sep 6;7(1):10702. doi: 10.1038/s41598-017-10800-5. Sci Rep. 2017. PMID: 28878296 Free PMC article.
MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis.
Huang X, Sun Q, Chen C, Zhang Y, Kang X, Zhang JY, Ma DW, Xia L, Xu L, Xu XY, Ren BH. Huang X, et al. Oncotarget. 2017 Aug 3;8(52):90315-90326. doi: 10.18632/oncotarget.19861. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163831 Free PMC article.
Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
Yuan Z, Li J, Hu R, Jiao Y, Han Y, Weng Q. Yuan Z, et al. Sci Rep. 2015 Nov 20;5:16482. doi: 10.1038/srep16482. Sci Rep. 2015. PMID: 26585370 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information